1.
Perceptions About Biosimilar Medicines Among Belgian Patients in the Ambulatory Care
2.
3.
4.
5.
Novel and recurrent PITX3 mutations in Belgian families with autosomal dominant congenital cataract and anterior segment dysgenesis have similar phenotypic and functional character...
Impact of health technology assessment and managed entry schemes on reimbursement decisions of centrally authorised medicinal products in Belgium
Off-Patent Biological and Biosimilar Medicines in Belgium: A Market Landscape Analysis
Urinary Levels of Bisphenol A, Triclosan and 4-Nonylphenol in a General Belgian Population
6.
7.
8.
9.
Is the contamination of the Belgian population by endocrine disruptors linked to thyroid disorders ?
2C-B draws attention on the Belgian market: description of the first of the 2Cs
2C-B Draws Attention on the Belgian Market - Description of an Amphetamine derivative
Association between endocrine disruptor contamination and thyroid hormone homeostasis in Belgian type 1 diabetic children.
From point prevalence surveys to continuous quality improvement in a teaching hospital in Belgium